JOHN VIERLING to Antineoplastic Agents
This is a "connection" page, showing publications JOHN VIERLING has written about Antineoplastic Agents.
Connection Strength
0.172
-
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
Score: 0.076
-
Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer. 2012 Nov; 20(11):2999-3008.
Score: 0.048
-
Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract. 2012 Jul; 8(4):e32-9.
Score: 0.048